Latest Mergers And Acquisitions News

Visionflex Group Limited reported a mixed quarter with a modest cash burn but strengthened its balance sheet through a significant debt-to-equity conversion and maintained solid funding capacity.

Mayfield Group Holdings has acquired a strategic industrial property adjacent to its BE Switchcraft operations, enabling operational synergies and capacity expansion to support a $30 million contract pipeline.

Lincoln Minerals has identified historic high-grade copper and gold samples at its Southern Eyre Project, complementing significant copper mineralisation confirmed at its flagship Minbrie Project in South Australia.

Rhythm Biosciences has begun commercialising its blood-based colorectal cancer test, ColoSTAT®, following key accreditations and validation. The company also secured a strategic partnership with NHS England and expanded its geneType™ platform globally.

Albright Metals has completed a key diamond drilling program at its Golden Pike Project in Canada and initiated antimony drilling at Bond Road, supported by a successful $1.98 million capital raise.

North Stawell Minerals has reported encouraging diamond drilling results at its Darlington Project in Victoria, revealing continued high-grade gold mineralisation at depth with strong parallels to the historic Mariners Lode.

EPX Limited has successfully raised nearly $295,000 through a Security Purchase Plan, supporting its recent acquisition of Wattwatchers and positioning the company for further expansion.

Auravelle Metals has reported significant high-grade gold intersections at its Sheoak Prospect in South Australia, extending the gold trend beyond 600 metres and identifying new targets at Sheoak East. Meanwhile, early drilling at its Crown Gold Project in Western Australia confirms extensive gold anomalism, supported by a successful $2.5 million capital raise to fund ongoing exploration.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Strickland Metals has announced a maiden inferred resource of 1.2 million ounces of gold at its Gradina Deposit, lifting the total Rogozna Project resources by 16% to 8.6 million ounces gold equivalent. The company plans an ambitious 60,000-metre drilling campaign in 2026 to further expand and define its Serbian gold-base metals assets.

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.